相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic and Clinicopathological Significance of the Aberrant Expression of β-Catenin in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Pablo Ramos-Garcia et al.
CANCERS (2022)
Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis
Pablo Ramos-Garcia et al.
ORAL ONCOLOGY (2022)
TERT Promoter Mutations and rs2853669 Polymorphism: Useful Markers for Clinical Outcome Stratification of Patients With Oral Cavity Squamous Cell Carcinoma
Silvia Giunco et al.
FRONTIERS IN ONCOLOGY (2021)
Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery
A. Moreira et al.
ESMO OPEN (2021)
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence
Yao Yu et al.
JCO PRECISION ONCOLOGY (2021)
Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis
Lizbeth K. Raju et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Promoter region mutations of the telomerase reverse transcriptase (TERT) gene in head and neck squamous cell carcinoma
Ismail Yilmaz et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2020)
Prognostic and Clinicopathological Significance of FADD Upregulation in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Miguel Angel Gonzalez-Moles et al.
CANCERS (2020)
Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx
Snjezana Dogan et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
Dehui Luo et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2018)
Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma
Kai-Ping Chang et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
The albatross plot: A novel graphical tool for presenting results of diversely reported studies in a systematic review
Sean Harrison et al.
RESEARCH SYNTHESIS METHODS (2017)
The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis
Kazuya Haraguchi et al.
APMIS (2017)
New prospects for targeting telomerase beyond the telomere
Greg M. Arndt et al.
NATURE REVIEWS CANCER (2016)
Telomerase reverse transcriptase potentially promotes the progression of oral squamous cell carcinoma through induction of epithelial-mesenchymal transition
Tengda Zhao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
Cheryl M. Koh et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
Larissa Shamseer et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
β-Catenin in oral cancer: An update on current knowledge
M. A. Gonzalez-Moles et al.
ORAL ONCOLOGY (2014)
Telomerase stimulates ribosomal DNA transcription under hyperproliferative conditions
Omar Garcia Gonzalez et al.
NATURE COMMUNICATIONS (2014)
Assessing Bias in Studies of Prognostic Factors
Jill A. Hayden et al.
ANNALS OF INTERNAL MEDICINE (2013)
Telomerase promotes efficient cell cycle kinetics and confers growth advantage to telomerase-negative transformed human cells
H. B. Fleisig et al.
ONCOGENE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Separation of telomerase functions by reverse genetics
Shibani Mukherjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Expressing findings from meta-analyses of continuous outcomes in terms of risks
Judith Anzures-Cabrera et al.
STATISTICS IN MEDICINE (2011)
Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders
Aline Correa Abrahao et al.
BRAZILIAN ORAL RESEARCH (2011)
Outlier and influence diagnostics for meta-analysis
Wolfgang Viechtbauer et al.
RESEARCH SYNTHESIS METHODS (2010)
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues
Eva-Maria Fabricius et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Telomerase modulates Wnt signalling by association with target gene chromatin
Jae-Il Park et al.
NATURE (2009)
Almost all articles on cancer prognostic markers report statistically significant results
Panayiotis A. Kyzas et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prognosis research: toward evidence-based results and a Cochrane methods group
Richard D. Riley et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma
Kolja Freier et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2007)
Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan
Huang-Hsu Chen et al.
ORAL ONCOLOGY (2007)
Evaluation of the quality of prognosis studies in systematic reviews
JA Hayden et al.
ANNALS OF INTERNAL MEDICINE (2006)
The telomerase reverse transcriptase regulates chromatin state and DNA damage responses
K Masutomi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity
KH Shin et al.
CLINICAL CANCER RESEARCH (2004)
Death receptor signaling regulatory function for telomerase:: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance
C Dudognon et al.
ONCOGENE (2004)
Human telomerase catalytic subunit gene re-expression is an early event in oral carcinogenesis
B Luzar et al.
HISTOPATHOLOGY (2004)
Controlling the risk of spurious findings from meta-regression
JPT Higgins et al.
STATISTICS IN MEDICINE (2004)
A DNA damage checkpoint response in telomere-initiated senescence
FD di Fagagna et al.
NATURE (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosis
RM Luiten et al.
BLOOD (2003)
Telomerase modulates expression of growth-controlling genes and enhances cell proliferation
LL Smith et al.
NATURE CELL BIOLOGY (2003)
HTERT associates with human telomeres and enhances genomic stability and DNA repair
GG Sharma et al.
ONCOGENE (2003)
Telomerase contributes to turnorigenesis by a telomere length-independent mechanism
SA Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
How should meta-regression analyses be undertaken and interpreted?
SG Thompson et al.
STATISTICS IN MEDICINE (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
TERT regulates cell survival independent of telomerase enzymatic activity
Y Cao et al.
ONCOGENE (2002)
Ribozyme-mediated telomerase inhibition induces immediate cell loss but not telomere shortening in ovarian cancer cells
G Saretzki et al.
CANCER GENE THERAPY (2001)
分享论文
